SCHEMBL6990176

SCHEMBL6990176

CC(C)(CC(=O)O)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.47
HIF1A Q16665 1/20 0.47
TSHR P16473 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MMP1 P03956 2/20 0.44
MMP13 P45452 2/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
HPGD P15428 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
PRSS1 P07477 2/20 0.42
PRSS2 P07478 2/20 0.42
PRSS3 P35030 2/20 0.42
FAAH O00519 1/20 0.42
ELANE P08246 1/20 0.42
PRTN3 P24158 1/20 0.42
CA5A P35218 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22895119 0.79 PRSS1 (0.47) TSHRSMN1; SMN2MMP1MMP13CA1
SCHEMBL8103623 0.77 CA2 (0.52) TSHRSMN1; SMN2MMP1MMP13CA1
SCHEMBL8745503 0.77 CA2 (0.52) TSHRSMN1; SMN2MMP1MMP13CA1
SCHEMBL22955288 0.76 CA1 (0.44) TSHRSMN1; SMN2MMP1MMP13CA1
SCHEMBL27840151 0.72 HSD17B10 (0.47) TSHRSMN1; SMN2MMP1MMP13CA1
SCHEMBL6995470 0.72 HMGCR (0.46) CYP2C19HIF1ATSHRALDH1A1POLB
SCHEMBL28142782 0.70 CA2 (0.54) TSHRSMN1; SMN2MMP1MMP13CA1
SCHEMBL473504 0.69 CYP2C19 (0.53) CYP2C19HIF1ASMN1; SMN2MMP8ALDH1A1
SCHEMBL8745506 0.69 CA1 (0.44) TSHRSMN1; SMN2MMP1MMP13CA1
SCHEMBL2198863 0.69 PRSS1 (0.58) TSHRSMN1; SMN2MMP1MMP13CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339692-A1 NOVEL COMPOUNDS FOR USE AS HIV PROTEASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2003-09-03 EP disclosed
US-6472404-B1 HIV protease inhibitors HOFFMANN-LA ROCHE INC. 2002-10-29 US disclosed
WO-2002042277-A1 NOVEL COMPOUNDS FOR USE AS HIV PROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-05-30 WO disclosed